Medical Product Communications That Are Consistent With the Food and Drug Administration Required Labeling -Questions and Answers

ICR 202107-0910-006

OMB: 0910-0856

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
ICR Details
0910-0856 202107-0910-006
Historical Inactive 201806-0910-008
HHS/FDA CDER
Medical Product Communications That Are Consistent With the Food and Drug Administration Required Labeling -Questions and Answers
Extension without change of a currently approved collection   No
Regular
Withdrawn and continue 07/29/2021
Retrieve Notice of Action (NOA) 07/29/2021
  Inventory as of this Action Requested Previously Approved
08/31/2021 36 Months From Approved 08/31/2021
9,720 0 9,720
38,880 0 38,880
0 0 0

This information collection supports agency guidance. The guidance provides third-party disclosure recommendations firms should include in their drug and device labeling and prescription drug and restricted device advertising that contain information not found in the FDA-required labeling for their medical products but that are “consistent with the FDA-required labeling” (as that term is explained in the guidance) if they choose to publicly disseminate such materials.

None
None

Not associated with rulemaking
Other Documents for OIRA Review

  86 FR 24868 05/10/2021
86 FR 39035 07/23/2021
Yes

1
IC Title Form No. Form Name
GFI: Medical Product Communications That Are Consistent with the FDA-Required Labeling – Questions and Answers

No
No

$0
No
    No
    No
No
No
No
No
Domini Bean 301 796-5733 domini.bean@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/29/2021


© 2024 OMB.report | Privacy Policy